STOCK TITAN

Boston Scien Cp Stock Price, News & Analysis

BSX NYSE

Company Description

Overview of Boston Scientific (BSX)

Boston Scientific Corporation (BSX) is a globally recognized medical technology company that develops, manufactures, and markets innovative, minimally invasive devices used in interventional procedures. With a diversified portfolio spanning the MedSurg and Cardiovascular segments, the company is dedicated to transforming patient care by addressing a broad range of complex health issues. Boston Scientific leverages robust clinical evidence and extensive research to design devices that improve diagnostic accuracy, therapeutic delivery, and overall procedure efficiency.

Core Business Areas and Product Offerings

The company is renowned for its contributions in several key areas:

  • Cardiovascular Therapies: Boston Scientific provides devices for procedures such as angioplasty, blood clot filtration, and innovative transcatheter heart valve replacements. Its technology supports physicians in managing arrhythmias, treating heart rhythm disorders, and addressing a variety of cardiovascular conditions with minimally invasive approaches.
  • Electrophysiology and Cardiac Rhythm Management: Through a series of advanced pacing leads, mapping systems, and ablation catheters, the company offers comprehensive solutions for treating irregular heart rhythms, including atrial fibrillation. Detailed mapping technologies and integrated navigation systems help optimize procedural outcomes and refine treatment strategies.
  • Interventional Oncology and Gastrointestinal Diagnostics: By developing devices tailored to minimally invasive tumor ablation and diagnostic interventions, Boston Scientific extends its expertise to interventional oncology and gastrointestinal procedures. These solutions are designed to reduce the overall cost of care by streamlining complex interventions.
  • Neuromodulation and Urological Devices: The company also manufactures and markets products that manage chronic pain and treat incontinence. These offerings reflect Boston Scientific's commitment to broad clinical challenges, always with a focus on precision and patient safety.

Innovation and Clinical Excellence

At the heart of Boston Scientific's strategy is a commitment to technological innovation. The company employs advanced engineering and rigorous clinical testing to continuously refine its product portfolio. Innovations such as cutting-edge pulsed field ablation systems and advanced intravascular diagnostic mapping technologies have been developed to enhance procedural efficiency and efficacy. Each product is underpinned by strong clinical evidence and supported by extensive research, ensuring that the devices meet high standards of safety and performance.

Market Position and Global Reach

Boston Scientific operates in a highly competitive and regulated industry, where continuous product innovation and clinical data play a crucial role in maintaining market credibility. Its broad geographic presence, with significant foreign sales, underscores its position as a key player in global healthcare markets. The company’s devices are marketed to healthcare professionals and institutions worldwide, which helps foster enduring trust and long-term strategic partnerships. Moreover, its comprehensive investment in research and development facilitates rapid adaptation to emerging clinical needs and evolving regulatory landscapes.

Operational Excellence and Customer Focus

Beyond technological prowess, Boston Scientific emphasizes operational excellence. Its streamlined manufacturing processes, commitment to quality control, and strong post-market surveillance systems ensure consistent product performance. The company places a high priority on understanding and addressing the unmet needs of physicians and patients alike, thereby building long-standing trust and reinforcing its reputation as an expert in minimally invasive interventional therapies.

Industry Terminology and Clinical Impact

Key industry terms such as minimally invasive interventional procedures, catheter ablation, diagnostic mapping, and FDA approved medical devices are integrated seamlessly within Boston Scientific's portfolio. This vocabulary not only highlights the company's expertise but also ensures that its scientific and clinical contributions are communicated clearly to both healthcare professionals and investors. The company's product development is informed by iterative clinical trials and data-driven insights, fostering an environment where patient-centric design and clinical performance converge.

Conclusion

Boston Scientific Corporation stands as a cornerstone in the medical technology industry, driven by a blend of clinical expertise, technological innovation, and a commitment to improving patient outcomes. Through its diverse product offerings and a relentless focus on research, the company enhances the standard of care in multiple clinical domains. As it navigates the complex landscape of global healthcare, Boston Scientific continues to prioritize safety, efficacy, and superior clinical performance, making it a trusted name among healthcare professionals and institutions worldwide.

Stock Performance

$101.90
0.00%
0.00
Last updated: April 26, 2025 at 16:00
54.43 %
Performance 1 year
$140.7B
Market Cap
1.5B
Shares outstanding

SEC Filings

No SEC filings available for Boston Scien Cp.

Financial Highlights

$16,747,000,000
Revenue (TTM)
$1,846,000,000
Net Income (TTM)
$1.25
Diluted EPS (TTM)
$3,435,000,000
Operating Cash Flow
11.02%
Net Profit Margin
15.54%
Oper. Profit Margin

Frequently Asked Questions

What is the current stock price of Boston Scien Cp (BSX)?

The current stock price of Boston Scien Cp (BSX) is $101.9 as of April 25, 2025.

What is the market cap of Boston Scien Cp (BSX)?

The market cap of Boston Scien Cp (BSX) is approximately 140.7B.

What is the revenue (TTM) of Boston Scien Cp (BSX) stock?

The trailing twelve months (TTM) revenue of Boston Scien Cp (BSX) is $16,747,000,000.

What is the net income of Boston Scien Cp (BSX)?

The trailing twelve months (TTM) net income of Boston Scien Cp (BSX) is $1,846,000,000.

What is the earnings per share (EPS) of Boston Scien Cp (BSX)?

The diluted earnings per share (EPS) of Boston Scien Cp (BSX) is $1.25 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Boston Scien Cp (BSX)?

The operating cash flow of Boston Scien Cp (BSX) is $3,435,000,000.

What is the profit margin of Boston Scien Cp (BSX)?

The net profit margin of Boston Scien Cp (BSX) is 11.02%.

What is the operating margin of Boston Scien Cp (BSX)?

The operating profit margin of Boston Scien Cp (BSX) is 15.54%.

What is the gross margin of Boston Scien Cp (BSX)?

The gross profit margin of Boston Scien Cp (BSX) is 68.61%.

What is the current ratio of Boston Scien Cp (BSX)?

The current ratio of Boston Scien Cp (BSX) is 1.08, indicating the company's ability to pay short-term obligations.

What is the gross profit of Boston Scien Cp (BSX)?

The gross profit of Boston Scien Cp (BSX) is $11,490,000,000 on a trailing twelve months (TTM) basis.

What is the operating income of Boston Scien Cp (BSX)?

The operating income of Boston Scien Cp (BSX) is $2,603,000,000.

What are the main business segments of Boston Scientific?

Boston Scientific operates primarily in the MedSurg and Cardiovascular segments. These segments focus on developing, manufacturing, and marketing devices used in minimally invasive interventional procedures across a variety of clinical applications.

What types of medical devices does Boston Scientific produce?

The company produces a wide array of devices including catheters, pacemaking systems, ablation devices, diagnostic mapping systems, and tools for interventional oncology, neuromodulation, and urological therapies. Its products emphasize minimally invasive techniques and are designed to improve clinical outcomes.

How does Boston Scientific ensure the quality and safety of its products?

Boston Scientific integrates rigorous clinical testing, strict regulatory compliance, and advanced manufacturing processes. Its products are supported by extensive clinical evidence and robust post-market surveillance, ensuring high standards of safety and performance.

In what ways has Boston Scientific demonstrated innovation in its field?

The company is known for its pioneering approach to medical technology, including the development of advanced pulsed field ablation systems and diagnostic mapping solutions. Its continuous investment in research and development facilitates the rapid introduction of innovative products that address unmet clinical needs.

How does Boston Scientific maintain a competitive edge in the medical device industry?

Boston Scientific maintains its competitive edge through a combination of technological innovation, a diversified product portfolio, and a strong global distribution network. By emphasizing minimally invasive procedures and robust clinical data, the company differentiates itself from its competitors.

What is the significance of FDA approvals for Boston Scientific?

FDA approvals are crucial as they validate the safety and efficacy of Boston Scientific's medical devices. These approvals enable the company to market its innovative products globally and provide assurance to healthcare providers and patients regarding the reliability of its technologies.

Who are the primary customers of Boston Scientific's products?

The primary customers are healthcare professionals and institutions that perform interventional procedures. This includes hospitals, specialized clinics, and cardiovascular centers around the world that rely on advanced medical devices for diagnostic and therapeutic interventions.

How does Boston Scientific contribute to clinical research and advancements in healthcare?

Boston Scientific actively participates in clinical trials and extensive research to continuously improve its device offerings. The company collaborates with top medical institutions worldwide to generate robust clinical evidence, thereby contributing to the advancement of interventional therapies and improved patient outcomes.